Research ArticleOriginal Article
Open Access

Trends in antimicrobial susceptibility patterns in King Fahad Medical City, Riyadh, Saudi Arabia

Sara M. Farah, Mohammed A. Alshehri, Tariq S. Alfawaz, Faisal A. Alasmeri, Abdulaziz A. Alageel and Dayel A. Alshahrani
Saudi Medical Journal March 2019, 40 (3) 252-259; DOI: https://doi.org/10.15537/smj.2019.3.23947

References

  1. ↵
    1. O'Neill J
    (2014) Antimicrobial resistance:tackling a crisis for the health and wealth of nations. The Review on Antimicrobial Resistance, 20.
  2. ↵
    1. World Health Organization
    (2014) Antimicrobial resistance:global report on surveillance (World Health Organization, Geneva).
  3. ↵
    1. Joshi S
    (2010) Hospital antibiogram:a necessity. Indian J Med Microbiol 28:277–280.
    OpenUrlPubMed
  4. ↵
    1. Al Johani SM,
    2. Akhter J,
    3. Balkhy H,
    4. El-Saed A,
    5. Younan M,
    6. Memish Z
    (2010) Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia (2010-2014). Ann Saudi Med 30:364–369.
    OpenUrlPubMedWeb of Science
  5. ↵
    1. Aly M,
    2. Balkhy HH
    (2012) The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries. Antimicrob Resist Infect Control 1:26.
    OpenUrl
  6. ↵
    1. Chaudhry LA,
    2. Al-Tawfiq JA,
    3. Zamzami MM,
    4. Al-Ghamdi SA,
    5. Robert AA
    (2016) Antimicrobial susceptibility patterns:a three-year surveillance study in a rehabilitation setting. Pan Afr Med J Pan 23:214.
    OpenUrl
  7. ↵
    1. Tomasz A
    (1997) Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 24:S85–S88.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Almazrou Y,
    2. Shibl AM,
    3. Alkhlaif R,
    4. Pirçon JY,
    5. Anis S,
    6. Kandeil W,
    7. et al.
    (2016) Epidemiology of invasive pneumococcal disease in Saudi Arabian children younger than 5 years of age. J Epidemiol Glob Health 6:95–104.
    OpenUrl
  9. ↵
    1. Shibl AM,
    2. Memish ZA,
    3. Al-Kattan KM
    (2012) Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Vaccine 30:G32–G36.
    OpenUrl
  10. ↵
    1. Alharbi NS,
    2. Al-Barrak AM,
    3. Al-Moamary MS,
    4. Zeitouni MO,
    5. Idrees MM,
    6. Al-Ghobain MO,
    7. et al.
    (2016) The Saudi thoracic society pneumococcal vaccination guidelines-2016. Ann Thorac Med 11:93.
    OpenUrl
  11. ↵
    1. Tariq Z
    (2016) Changes in susceptibility pattern of streptococcus pneumonia at Tawam Hopsital in Al Ain, United Arab Emirates durin (2004-2011). Pakistan Armed Forces Medical Journal (66):14–21.
  12. ↵
    1. Jamsheer A,
    2. Rafay AM,
    3. Daoud Z,
    4. Morrissey I,
    5. Torumkuney D
    (2016) Results from the survey of antibiotic resistance (SOAR) 2011-13 in the gulf states. 2016. J Antimicrob Chemother 71:i45–i61.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Mokaddas E,
    2. Albert MJ
    (2016) Serotype distribution and penicillin-non-susceptibility of Streptococcus pneumoniae causing invasive diseases in Kuwait:A 10-year study of impact of pneumococcal conjugate vaccines. Expert Rev Vaccines 15:1337–1345.
    OpenUrl
  14. ↵
    1. Balsells E,
    2. Guillot L,
    3. Nair H,
    4. Kyaw MH
    (2017) Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era:A systematic review and meta-analysis. PloS One 12:e0177113.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Jabarin B,
    2. Pitaro J,
    3. Lazarovitch T,
    4. Gavriel H,
    5. Muallem-Kalmovich L,
    6. Eviatar E,
    7. et al.
    (2017) Decrease in pneumococcal otitis media cultures with concomitant increased antibiotic susceptibility in the pneumococcal conjugate vaccines era. Otol Neurotol 38:853–859.
    OpenUrl
    1. Angoulvant F,
    2. Cohen R,
    3. Doit C,
    4. Elbez A,
    5. Werner A,
    6. Béchet S,
    7. et al.
    (2015) Trends in antibiotic resistance of streptococcus pneumoniae and haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction. BMC Infect Dis 15:236.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Richter SS,
    2. Diekema DJ,
    3. Heilmann KP,
    4. Dohrn CL,
    5. Riahi F,
    6. Doern GV
    (2014) Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States. Antimicrob Agents Chemother 58:6484–6489.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Alzomora O,
    2. Alhajjarb S,
    3. Aljobairc F,
    4. Alenizid A,
    5. Alodyanie A,
    6. Alzahran M,
    7. et al.
    (2017) Management of community-acquired pneumonia in infants and children:Clinical practice guidelines endorsed by the Saudi Pediatric Infectious Diseases Society. International Journal of Pediatrics and Adolescent Medicine (4):153–158.
  19. ↵
    1. AL Yousef SA,
    2. Mahmoud SY,
    3. Taha EM
    (2013) Prevalence of Methicillin-Resistant Staphylococcus aureus in Saudi Arabia:systemic review and meta-analysis. African Journal of Clinical and Experimental Microbiology 14:146–154.
    OpenUrl
  20. ↵
    1. Alaklobia F,
    2. Aljobaira F,
    3. Alrashodb A,
    4. Alhababic R,
    5. Alshamrania M,
    6. Alaminb W,
    7. et al.
    (2015) The prevalence of community-associated methicillin-resistant Staphylococcus aureus among outpatient children in a tertiary hospital:A prospective observational study in Riyadh, Saudi Arabia. International Journal of Pediatrics and Adolescent Medicine 2:136–140.
    OpenUrl
  21. ↵
    1. Centers for Disease Control and Prevention
    MRSA Tracking, Available from: https://www.cdc.gov/mrsa/tracking/index.html. [Update 2017;Accessed 2018 May 30 May].
  22. ↵
    1. Lee BY,
    2. Bailey RR,
    3. Smith KJ,
    4. Muder RR,
    5. Strotmeyer ES,
    6. Lewis GJ,
    7. et al.
    (2010) Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission:an economic model and analysis. Infect Control Hosp Epidemiol 31:598–606.
    OpenUrlCrossRefPubMed
    1. Lucet JC,
    2. Paoletti X,
    3. Lolom I,
    4. Paugam-Burtz C,
    5. Trouillet JL,
    6. Timsit JF,
    7. et al.
    (2005) Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 31:1051–1057.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. West TE,
    2. Guerry C,
    3. Hiott M,
    4. Morrow N,
    5. Ward K,
    6. Salgado CD
    (2006) Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 27:233–238.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Hübner C,
    2. Hübner NO,
    3. Wegner C,
    4. Flessa S
    (2015) Impact of different diagnostic technologies for MRSA admission screening in hospitals-a decision tree analysis. Antimicrob Resist Infect Control 4:50.
    OpenUrl
  26. ↵
    1. Ghazal SS,
    2. Hakawi AM,
    3. Demeter CV,
    4. Joseph MV,
    5. Mukahal MA
    (2011) Intervention to reduce the incidence of healthcare-associated methicillin-resistant Staphylococcus aureus infection in a tertiary care hospital in Saudi Arabia. Infect Control Hosp Epidemiol 32:411–413.
    OpenUrlPubMed
  27. ↵
    1. Flokas ME,
    2. Karanika S,
    3. Alevizakos M,
    4. Mylonakis E
    (2017) Prevalence of ESBL-producing Enterobacteriaceae in pediatric bloodstream infections:a systematic review and meta-analysis. PloS One 12:e0171216.
    OpenUrlPubMed
  28. ↵
    1. Zowawi HM,
    2. Balkhy HH,
    3. Walsh TR,
    4. Paterson DL
    (2013) β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev 26:361–380.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section